Founder and Chief Executive Officer of ImmuMap Services, Thomas Mørch Frøsig, is PhD in tumor immunology and has years of experience with advanced T cell detection techniques. Thomas’ work in this field has resulted in high-impact scientific publications on mapping T cell reactivity to cancer through the use of multicolor flow cytometry and on developing new techniques for the generation of MHC multimer reagents.
COO & QA Manager Houman Pourhassan, PhD, has a background in immuno-oncology and drug development. Houman’s area of expertise includes multicolor flow cytometry, animal cancer models, and mammalian microbiology. In addition to high-impact scientific publications in the field of immunomodulation and nanoparticle anticancer drugs, he is experienced in industry standard GMP and PRINCE2® project management.
Associate Cecilie is BSc Eng from the Danish Technical University and currently attending the MSc programme in Biotechnology engineering.
Cecilie has broad experience in both scientific, sales and administrative areas.
Research Scientist Philip V. Hansen, has a background as MSc of biotechnology from the University of Copenhagen, with specialization in cell physiology, genetic editing and process optimization. He has been involved with life science business and has worked with investment strategies, business evaluation and project management.